Voters in California have approved Proposition 14, which will pump billions of dollars into the state's stem cell research program. The Associated Press called the vote on Thursday, with 51 percent of ballots for and 49 percent against.
The result will allow the state to borrow $5.5 billion from investors for its stem cell agency, the California Institute for Regenerative Medicine (CIRM). The moneywhich taxpayers will repay with interest over the next 30 yearswill enable the institute to stay open, expand its research programs, and build new facilities.
Some $1.5 billion of the money will be spent researching conditions affecting the brain and central nervous system, such as Alzheimer's, Parkinson's, epilepsy, and stroke.
Unlike specialized cellssuch as blood cells or bone cellsstem cells do not have a specific job. Think of them as the raw materials of our bodies. When they divide, they can either renew and make new stem cells, or turn into specialized cells.
Despite making headlines for years, stem cell research is still in its early stages, with some treatments that have appeared to have worked in animals now going into clinical trials. These include treatments for macular degeneration, a common cause of blindness, as well as stroke, Lou Gehrig's disease, and spinal cord injuries.
It is hoped growing stem cells into specialized cells could also one day be used to replace damaged tissue and organs, for instance by helping the pancreas produce insulin in people with diabetes.
Currently, stem bone marrow transplantation is the most common form of stem cell therapy, used to treat blood cancer patients. Stem cell therapy has also been used for grafts of corneal stem cells, as well as skin grafts for burns victims.
As well as creating treatments, stem cell research can also help scientists understand diseases. Observing the cells in a lab as they turn into specialized cells, for instance, can provide clues on how we develop certain conditions.
There are a number of stem cells: embryonic stem cells, adult stem cells, adult stem cells tweaked to behave like embryonic stem cells, and stem cells found in the amniotic fluid and the umbilical cord of babies.
The controversy around stem cell research largely lies in the use of embryonic stem cells. These are taken from human embryos in their early stages of development. Opponents have likened this to abortion, although others disagree with this stance.
Embryonic stem cells used in research come from donations from IVF clinics, where an egg is fertilized with a sperm but not implanted into a patient because it is not needed. Embryonic stem cells are preferred over adult stem cells, as it may not be possible to specialize the latter and they are more likely to have abnormalities. But research suggests that it may be possible to turn adult stem cells into a wider range of specialized cells than previously thought, which may make them more useful.
In 2001, the Bush administration banned federal funding for stem cell research. This lead real estate developer Robert N. Klein II to initiate and help fund Proposition 71 in California. The aim was to enshrine the right to carry out stem cell research in the state's constitution, and establish CIRM. Klein was motivated by his son's experience with Type 1 diabetes, and his mother's Alzheimer's diagnosis. In 2004, Californians voted in favor of the proposition.
The institute has performed 64 clinical trials, and published over 3,000 scientific articles on the subject. But 16 years after Proposition 71 passed, CIRM started to run out of funds, and stopped accepting applications for new projects last year. This prompted the Californians for Stem Cell Research, Treatments and Cures political action committee (PAC) to lead the campaign for Proposition 14. Klein was among its supporters, as well as California governor Gavin Newsom, LA mayor Eric Garcetti, and the Michael J. Fox Foundation established by the Back to the Future actor and Parkison's disease patient who is its namesake.
On November 1, the foundation urged people via Twitter to vote in favor of Prop 14 to fund research on neurological disease. "Without this proposition vital research may come to a halt, delaying new treatments for people with," it said.
See the article here:
As California Passes Prop 14, What Is Stem Cell Research and Why Is It Controversial? - Newsweek
- Immune Complex Shaves Stem Cells to Protect against Cancer - February 4th, 2025
- Should I bank my newborn's umbilical cord blood? | BabyCentre - February 4th, 2025
- Characteristics of Parthenogenetic Stem Cells and Their Potential ... - February 4th, 2025
- Cord Blood Banking Leader Cryo-Cell Announces Regular Quarterly Cash Dividend and Pause of Strategic Initiatives - Business Wire - January 31st, 2025
- Edmontons Lois Hole Hospital collects 9,000 units of cord blood since launching 10 years ago - CityNews Edmonton - January 21st, 2025
- Lois Hole Hospital for Women celebrates 10 years as cord blood collection site - CTV News - January 21st, 2025
- LMRUK: 10 years of fighting blood cancer - Charity Today News - January 21st, 2025
- A phase 2 pilot study of umbilical cord blood infusion as an adjuvant consolidation therapy in elderly patients with acute myeloid leukemia -... - December 22nd, 2024
- Hope for the treatment of alzheimers disease may lie in umbilical cord stem cells - The Portugal News - December 20th, 2024
- Stem Cells: Hope on the Horizon for Preterm Babies - Monash University - December 17th, 2024
- Cord Blood & Uses to Treat Disease About Stem Cells - December 17th, 2024
- LMRUK: New mothers share why theyre banking their babies cord blood stem cells - Charity Today News - November 29th, 2024
- scRNA-seq revealed transcriptional signatures of human umbilical cord primitive stem cells and their germ lineage origin regulated by imprinted genes... - November 26th, 2024
- Cord Blood Banking FAQs - Cord For Life - November 25th, 2024
- Hematopoietic Stem Cell Transplantation Market: Industry Analysis and Forecast 2024-2033 - openPR - November 22nd, 2024
- Thousands of donations, fewer than 2% used. Why cord blood transplants are so rare - CBC News - November 18th, 2024
- Stem cells: the alternative solution to umbilical cord blood - Genethique - November 10th, 2024
- Chapter 64 Role of Umbilical Cord Blood Transplantation - October 30th, 2024
- Major Trend Transforming the Stem Cell Market in 2024: Advancements in Automated Stem Cell Analysis Systems - EIN News - October 30th, 2024
- Stem cell therapies for neurological disorders: current progress ... - October 22nd, 2024
- OmniaBio Announces Opening of New Commercial Manufacturing Facility in Canada, Bringing Life-Saving Cell and Gene Therapies to Patients - AsiaOne - October 18th, 2024
- Click N' Play STEM Lesson on Cord Blood Launches for Teachers this November - EIN News - October 18th, 2024
- Black, White Cancer Patients Now Benefit Equally From Cord Blood Therapy - HealthDay - October 4th, 2024
- What Are Leukemia and Lymphoma and How Are They Treated? - LVHN News - September 20th, 2024
- Advanced Treatment for Leukemia and Lymphoma at Lehigh Valley Topper Cancer Institute - LVHN News - September 18th, 2024
- Functional stem cells successfully grown in lab for the first time - The Star Online - September 14th, 2024
- Umbilical Cord Blood Stem Cells as Third-party Adjuvant Infusions in Human Leukocyte Antigen Antibody-Positive Patients Undergoing Haploidentical... - September 12th, 2024
- Cord Blood Banking Market Size to Surpass USD 65.6 Billion by 2032 | With 7.9% CAGR - openPR - September 12th, 2024
- Blood stem cell breakthrough could have massive impact on patients - Yahoo! Voices - September 8th, 2024
- Scientists have grown blood stem cells in the laboratory - TURKMENPORTAL - September 4th, 2024
- Global Cord Blood Product Market Poised for Significant Growth: Projected to Reach USD 1,341.7 Million by 2034 | Future Market Insights, Inc. - Yahoo... - September 2nd, 2024
- Global Allogeneic Stem Cell Transplantation Market Expected to Grow to $6.75 Billion by 2031 - WhaTech - August 31st, 2024
- Global Cord Blood Product Market Poised for Significant Growth: Projected to Reach USD 1,341.7 Million by 2034 | Future Market Insights, Inc. -... - August 31st, 2024
- Expansion Of Cord Blood-derived CD34 Cells In A Hollow-Fiber Bioreactor With 10% Standard Cytokine Concentration - BioProcess Online - August 22nd, 2024
- New Study: These Bizarre Blood-Sucking Fish Have a Jaw-Dropping Evolutionary Origin - SciTechDaily - July 31st, 2024
- Cord blood banking industry faces scrutiny over unproven claims and high costs - News-Medical.Net - July 28th, 2024
- Stem cells donated 15 years ago let poorly boy, five, leave home for the first time in six months - Express & Star - July 26th, 2024
- Cord blood stem cells transferred from Guangdong to treat girl with thalassemia - Hong Kong Standard - July 26th, 2024
- Cord Blood Banking Curative Benefits Often Oversold to Parents: NYT Investigation - AboutLawsuits.com - July 22nd, 2024
- Umbilical cord stem cells donated in 2008 transform life of five-year-old boy with rare genetic disorder - The Independent - July 22nd, 2024
- Boy, 5, diagnosed with deadly rare condition has life transformed after stem cell transplant from umbilical cord blood - Sky News - July 22nd, 2024
- Stem cells donated 15 years ago let poorly boy, five, leave home for the first time in six months - Shropshire Star - July 22nd, 2024
- Ottawa mother raising awareness on importance of donating umbilical cord blood - CTV News Ottawa - July 22nd, 2024
- Inside a blood cord bank: How facilities store and maintain the quality of units - CNA - July 8th, 2024
- Exploring the potential of predicted miRNAs on the genes involved in the expansion of hematopoietic stem cells ... - Nature.com - July 5th, 2024
- Overview of Umbilical Cord Blood - Stanford Medicine - July 5th, 2024
- Comparison of the therapeutic effects of human umbilical cord blood-derived mesenchymal stem cells and adipose ... - Frontiers - July 5th, 2024
- A Review of Placenta and Umbilical Cord-Derived Stem Cells and the Immunomodulatory Basis of Their Therapeutic ... - Frontiers - July 2nd, 2024
- Jacques Galipeau, MD, on International Insights Into Cell and Gene Therapy Development - CGTLive - June 30th, 2024
- Stem Cell Therapy Market to Hit $63.23 billion by 2031, at a CAGR of 22.6%, says Coherent Market Insights - GlobeNewswire - June 28th, 2024
- Hematopoietic stem cell transplantation (HSCT) Market Future Growth Trends, Upcoming Opportunities and ... - openPR - June 24th, 2024
- Global Biopreservation Market Forecast Report 2024-2029: Advances in Biobanking and Growing Trend of Conserving ... - GlobeNewswire - June 4th, 2024
- Cord Blood Banking Services Market to Witness Impressive Growth, Reaching USD 4.5 Billion by 2030 - EIN News - May 27th, 2024
- Department of Health Abu Dhabi and M42 launch regions largest hybrid cord blood bank - ZAWYA - May 15th, 2024
- Cord Blood Banking - Stanford Medicine Children's Health - May 8th, 2024
- Umbilical Cord Blood Transplants: Current Status and Evolving Therapies - May 8th, 2024
- Embattled Cordlife receives letter of demand from client for breach of contract - The Straits Times - May 4th, 2024
- From Cord Blood to Microbiome; The evolution of Rotary's gift to the people of WA - Lifeblood - May 2nd, 2024
- Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immune ... - Nature.com - April 28th, 2024
- Hitting the pavement for cord blood research | Cranbourne Star News - Cranbourne Star News - April 28th, 2024
- One year to test 200 Cordlife samples 'totally unjustified': Global cord blood banking experts - The Straits Times - April 15th, 2024
- Clinical trial: First cardiac bioimplants for treatment of myocardial infarction using umbilical cord stem cells - Medical Xpress - April 7th, 2024
- The umbilical cord: a rich and ethical stem cell source to advance ... - March 30th, 2024
- Story of discovery: getting a Notch up on cord blood cell ... - March 30th, 2024
- Cord Blood Transplants | Memorial Sloan Kettering Cancer Center - March 30th, 2024
- Therapeutic effect and study of human umbilical cord blood mononuclear cells in patients with ischaemic bowel ... - Nature.com - March 17th, 2024
- Global Cord Blood & Tissue Banking Industry Report 2024: The Vast Majority of the Global Cord Blood Market is Now ... - PR Newswire - March 15th, 2024
- Improving Transplant Outcomes and Cell Therapy Approaches - RegMedNet - March 9th, 2024
- The inhibition of ADAM17 in cord blood stem cell-derived CD16+ NK cells to enhance their cytotoxicity against acute ... - ScienceDirect.com - March 1st, 2024
- Beating Blood Cancer through Recycling - a Community crowdfunding project in Liverpool by Kate Williams - Crowdfunder UK - February 24th, 2024
- Cord Blood Registry (CBR ) by CooperSurgical and Fulgent Genetics Launch Innovative Genetic Testing - Investing.com Canada - February 9th, 2024
- Young cancer patient with 'no hope' of recovery saved by baby's umbilical cord - Study Finds - February 9th, 2024
- Global Cord Blood & Tissue Banking Industry Report 2024 - The Vast Majority of the Global Cord Blood Market is Now ... - ACROFAN - January 26th, 2024
- Finding the optimal combination of anticancer drug administration for the conditioning of cord blood transplantation - Medical Xpress - January 26th, 2024
- Cord Blood Banking Market Sales and Revenue Report 2023-2032 - WhaTech Technology and Markets News - January 26th, 2024
- Global Cord Blood & Tissue Banking Industry Report 2024 - The Vast Majority of the Global Cord Blood Market is Now ... - ACROFAN USA - January 24th, 2024
- Global Biobanking Market Size To Exceed USD 97.5 Billion By 2032 | CAGR of 5.8% - GlobeNewswire - January 24th, 2024
- The use of cryopreservation in life saving research - The Manufacturer - January 24th, 2024
- CD19-targeted CAR NK cell therapy achieves promising one-year results in patients with B-cell malignancies - Medical Xpress - January 18th, 2024
- Cord blood banking comes at a high cost to babies - STAT - STAT - January 18th, 2024
Recent Comments